Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04529109 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Daily Disposable Etafilcon A Cosmetic Contact Lenses
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT04529109 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 58 participants.
The verdict
NCT04529109, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
This will be a randomized, double-masked, bilateral, cross-over, 2 treatment by 2 period dispensing study. There will be 4 visits. There will be a 2 to 5 day washout period between treatments.
Interventions
- DEVICE etafilcon A investigational cosmetic lens 1
- DEVICE etafilcon A investigational cosmetic lens 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2020-08-13 |
| Est. Completion | 2020-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04529109
The ClinicalTrials.gov registry entry for NCT04529109 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which etafilcon A investigational cosmetic lens 1 is the first listed.
NCT04529109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04529109 about?
NCT04529109 is a clinical study titled "Clinical Evaluation of Daily Disposable Etafilcon A Cosmetic Contact Lenses". This will be a randomized, double-masked, bilateral, cross-over, 2 treatment by 2 period dispensing study. There will be 4 visits. There will be a 2 to 5 day washout period between treatments.
What is the current status of trial NCT04529109?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2020-08-13. Estimated completion is 2020-09-15.
What interventions are being tested in trial NCT04529109?
The interventions under investigation include: etafilcon A investigational cosmetic lens 1 (DEVICE), etafilcon A investigational cosmetic lens 2 (DEVICE).
Who is sponsoring clinical trial NCT04529109?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.